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Open access under tThis study was designed to examine the antioxidant activity in vitro of novel mono- and diselenide
compounds. We compared whether the formation of p-methyl-selenol from compounds 1-phenyl-
3-(p-tolylselanyl)propan-2-amine (C1) and 1,2-dip-tolyldiselenide (C4) and o-methoxy-selenol from
compounds 1-(2-methoxyphenylselanyl)-3-phenylpropan-2-amine (C2) and 1,2-bis(2-methoxyphenyl)
diselenide (C3) may be involved in their antioxidant effects. The compounds were tested against Fe(II)
and sodium nitroprusside (SNP)-induced lipid peroxidation in rat brain and liver homogenates. Likewise,
the antioxidant capacity of the compounds was assessed by their ability to decolorize the DPPH radical as
well as the Fe(II) chelating assay through the reduction of molybdenum(VI) (Mo6+) to molybdenum(V)
(Mo5+). This colorimetric assay was also used to quantify thiol peroxidase (GPx) and oxidase activity
and thioredoxin reductase (TrxR) activity. The results showed that the novel selenide compounds inhibit
the thiobarbituric acid reactive species (TBARS) induced by different pro-oxidants, but the monoselenides
effects were signiﬁcant only at concentrations higher than the concentrations of the diselenides. Simi-
larly, the total antioxidant activity was higher in the diselenides. Moreover, GPx and TrxR activity was
only observed for the diselenides, which indicates that these compounds are more stable selenol mole-
cules than monoselenides.
 2013 Elsevier Ltd. Open access under the Elsevier OA license. 1. Introduction
Oxygen metabolism, which typically occurs in aerobic organ-
isms, allows energy formation mediated by the mitochondrial elec-
tron transfer system (Puntel et al., 2013). However, oxygen
metabolism also leads to the production of small quantities of
reactive oxygen species (ROS), such as superoxide (O2 ), hydroxyl
radical (OH) and hydrogen peroxide (H2O2) (Mugesh et al.,
2001). Additionally, an aerobe is able to produce reactive nitrogen
species (RNS), such as peroxynitrite (ONOO) and nitric oxide
(NO), which are also as strong biological oxidants (Nathan and
Ding, 2010). Accordingly, the imbalance between ROS/RNS forma-
tion and the enzymatic/non-enzymatic antioxidant system is asso-
ciated with many diseases, such as Alzheimer’s, myocardial
infarction, atherosclerosis, and Parkinson’s, and in other patholog-
ical conditions, including senescence (Ji et al., 2003; Salmon et al.,
2010; Schon and Przedborski, 2011).
Similarly, several research groups developed techniques to cre-
ate potential antioxidant molecules using chalcogen elements in
their structure, and thus, some of these new compounds were55 3220 8978.
he Elsevier OA license. characterized as strong free radical scavengers. (Gutteridge and
Halliwell, 1992). For example, the organoselenium compounds
have shown mimetic glutathione peroxidase-like activity (GPx)
and also act as substrates of thioredoxin reductase (TrxR). There-
fore, these compounds might represent novel therapeutic targets
for diseases caused by oxidative stress (Arteel and Sies, 2001).
The antioxidant effects of organoselenium compounds, such as
ebselen and diphenyl diselenide (DPDS), have been shown to be
due to their ability to generate a selenol/selenolate chemical form
(Nogueira and Rocha, 2010). The selenolate group is a stronger
nucleophile than its thiolate analog, which confers stronger reduc-
ing power to a given selenol group than the analog thiol group
(Nogueira and Rocha, 2011).
However, although the selenol groups are less abundant than
thiols and are found only in a small number of selenoproteins, they
exhibit a stronger nucleophilicity than their sulfur analogs (Lu
et al., 2009). In brief, the presence of selenium (Se) in selenocys-
teine reduces the enzymatic pKa, compared to the sulfhydryl
enzyme, and therefore leads to Se ionization, forming a selenol
group (Gutteridge and Halliwell, 1992).
According to the proposed mechanism, the selenol complex
(enzyme-SeH) could react with hydrogen peroxide or other hydro-
peroxides to produce selenic acid (enzyme-SeOH), which is capable
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form water (Nogueira and Rocha, 2010).
Previous studies reported that the DPDS antioxidant effect was
better than that of ebselen, especially in the GPx-like action, and
wasmainly due to the formation of two selenol structures after inter-
action with reducing thiol groups (Nogueira et al., 2004). However,
the instability of the selenol complex makes it difﬁcult to detect
any antioxidant effects during in vitro studies (Bhabak and Mugesh,
2010). Therefore, theemergenceof classic, structural organoselenium
compound analogs can promote the stability of the selenol (Balk-
rishna et al., 2011). Indeed, the structural inclusion of a basic amino
acidnitrogennear the seleniumcan increase the antioxidant capacity
to create a more stable selenol molecule (Hassan et al., 2012).
Consequently, this study evaluates two different classes of orga-
noselenium compounds, monoselenides (b-selenoamines) and
diselenides (analogs of DPDS), using various antioxidant assays.
The b-selenoamine chemical structure includes amino groups (C1
and C2) and the diselenides consist of methyl or methoxy group
modiﬁcations (C3 and C4, respectively) (Fig. 1).
The aim of this study was to evaluate the antioxidant capacity
using in vitromodels of the compounds cited above and to associate
the effects with the capacity of these molecules to form a more sta-
ble selenol once the theoretical compounds C1 and C4 generate p-
methyl-selenol and compounds C2 and C3 form o-methoxy-selenol.2. Materials and methods
2.1. Animals
Male, adult Wistar rats (200–250 g) from our own breeding col-
ony were used. The animals were maintained on a 12-h light: 12-h
dark cycle, at a room temperature of 22–24 C and with free access
to food and water. The animals were treated according to standardFig. 1. Chemical structure and nomenclature of the b-selenoamines (C1 and C2) and
analogs of diphenyl diselenide (C3 and C4).guidelines of the Committee on Care and Use of Experimental Ani-
mal Resources.
2.2. Chemicals
Thiobarbituric acid (TBA), malonldialdehyde (MDA), diphenyl-
2’picrylhydrazyl (DPPH), adenine dinucleotide phosphate
(NADPH), benzenethiol, Tris–HCl, sodium dodecyl sulfate (SDS),
ethylene diamine tetra acetic acid (EDTA) and dimethyl sulfoxide
(DMSO) were obtained from Sigma (St. Louis, MO). Fe(II) sulfate,
sodium nitroprusside (SNP), ascorbic acid, hydrogen peroxide, ace-
tic acid, 5.5’-dithiobis(2-nitrobenzoate) (DTNB), NaCl, KCl, Na2-
HPO4, KH2PO4 and ethanol were obtained from Merck (Rio de
Janeiro, RJ, Brazil).
2.3. Compounds
The mono- and diselenides were prepared following previously
described methods (Salman et al., 2012), and the purity of the
products was accessed by hydrogen and carbon nuclear magnetic
resonance and gas chromatography. The compounds tested were
1-phenyl-3-(p-tolylselanyl)propan-2-amine (C1), 1-(2-methoxy-
phenylselanyl)-3-phenylpropan-2-amine (C2), 1,2-bis(2-methoxy-
phenyl)diselenide (C3), and 1,2-bisp-tolyldiselenide (C4). All the
compounds are dissolved in DMSO.
2.4. Tissue preparation
Animals were sacriﬁced by decapitation. The brain and liver tis-
sues were removed and immediately placed on ice. The tissues
were homogenized in Tris–HCl 10 mM and centrifuged for
10 min at 2000 rpm. The supernatant fraction (S1) was collected
immediately for the assays.
2.5. Sample preparation
Heparinized venous blood previously obtained from healthy
volunteer donors from the Hospital of Federal University of Santa
Maria (UFSM), Santa Maria, RS, Brazil. The study protocol was re-
viewed and approved by the appropriate institutional review board
following the Guidelines of the Committee of UFSM
(0089.0.243.000-07). The erythrocytes were separated by centrifu-
gation (480g for 10 min at room temperature) and the plasma was
aspirated. The cell pellet was washed three times with phosphate
buffer-saline (6.1 mM and pH 7.4, containing 150 mM NaCl). The
leukocytes were separate and utilized in the cell viability analysis.
2.6. Puriﬁcation of hepatic TrxR
The rat livers were homogenized in buffered saline (137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4 – pH 7.3)
and centrifuged at 13,000g for 30 min at 4 C. The supernatant frac-
tion was collected for TrxR isolation and dialyzed against buffered
saline for 24 h to remove low molecular weight thiols. The dialy-
sate was heated at 55 C for 10 min, cooled, and centrifuged at
13,000g for 30 min (Wagner et al., 2010). The supernatant was
used for the TrxR assay.
2.7. TBARS assay
The capacity to prevent end products of lipid peroxidation was
determined in tissue samples as previously described (Ohkawa
et al., 1979). Aliquots of brain and liver supernatants (100 lL of
S1) were incubated for 60 min with freshly prepared Fe(II)
(10 lM) or SNP (5 lM) in the absence or presence of different con-
centrations of the compounds C1–C4 (6.25, 12.5, 25, 50 lM) in a
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was stopped by the addition of SDS (ﬁnal concentration of
1.35%), and lipid peroxidation products were measured by the
addition of acetic acid/HCl buffer, pH 3.4 and 0.6% TBA, pH 6.0.
The color reaction was developed by incubating tubes in boiling
water for 60 min. TBARS levels were measured at 532 nm.2.8. DPPH radical scavenging method
The radical scavenging activities of the compounds were deter-
mined as previously described (Brand-Williams et al., 1995). Each
compound was tested at 6.25, 12.5, 25, 50, 100, 200, and 400 lM in
10% DMSO. Seven different concentrations of ascorbic acid (6.25;
12.5; 25; 50; 100; 200; 400 lM) were used as positive controls.
DPPH (diluted in ethanol) was added to ﬁnal concentration of
0.3 mM and allowed to react at room temperature for 30 min in
dark conditions. The absorbance was measured at 518 nm using
Spectra Max Plate Reader M2 (Molecular Devices), Sunnyvale,
California, USA.2.9. Total antioxidant capacity assay
The total antioxidant potential of the mono- and diselenides
was evaluated by the phosphomolybdenum method as previously
described (Prieto et al., 1999). A sample solution aliquot in ethanol
(0.3 ml) was combined in a vial with reagent solution (0.6 M sulfu-
ric acid, 28 mM sodium phosphate and 4 mM ammonium molyb-
date, 3 ml). The compounds were tested a concentration of
400 lM. The vials were capped and incubated in a water bath at
95 C for 90 min. After cooling the mixture to room temperature,
the absorbance was measured at 695 nm against a blank control.2.10. Thiol-peroxidase-like activity assay
The GPx catalytic activity of mono- and diselenides was evalu-
ated utilizing 10 mM benzenethiol (PhSH) as a substrate, as previ-
ously described (Iwaoka and Tomoda, 1994). The H2O2 reduction
was monitored at 305 nm for 150 s. The compounds were tested
at concentrations of 200 and 400 lM. DMSOwas used as a negative
control (vehicle).2.11. Thiol-oxidase activity assay
Thiol oxidase activity of 200 and 400 lM concentrations of the
compounds (C1–C4) was determined in a medium containing
10 mM Tris/HCl buffer (pH 7.4) and 1 mM glutathione or PhSH.
An aliquot of 100 lL was removed at different time points (0, 30,
60 and 120 min) and added to a solution containing 0.5 mM DTNB
and 10 mM Tris/HCl buffer (in the absence of thiol oxidation a
maximum of 100 nmol of –SH/ml can be found). The absorbance
of each sample was measured at 412 nm (Ellman, 1959).2.12. NADPH oxidation by TrxR using the selenide compounds as
substrates
The reduction of mono- and diselenides (15 lM) by rat hepatic
TrxR was performed by a modiﬁcation of the method previously
described by Holmgren and Bjornstedt (1995). TrxR was mixed
with a medium containing 10 mM Tris–HCl, 1 mM EDTA, pH 7.5,
in the presence or absence of selenide compounds and then, the
reaction was started by adding NADPH (ﬁnal concentration
120 lM).2.13. Fe(II)-chelating assay
The Fe(II)-chelating ability of compounds was determined using
a modiﬁed method of Puntel et al. (2005). Freshly prepared
500 lmol/L Fe(II) (150 lL) was added to a reaction mixture con-
taining 168 lL of 0.1 mol/L Tris–HCl (pH 7.4), 218 lL saline and
the compounds (100 lM). The reaction mixture was incubated
for 5 min prior to the addition of 13 lL of 0.25% 1,10-phenanthro-
line (w/v). The absorbance was then measured at 510 nm in a
spectrophotometer.2.14. Cell viability analysis
The percentages of viable and nonviable leukocytes in samples
incubated (90 min) with the compounds (100 lM) were deter-
mined by Trypan blue following the method of Mischell and Shiigi
(1980). Cell viability was calculated as the number of living cells
divided by the total number of cells multiplied by 100 (Mischell
and Shiigi, 1980).2.15. Protein quantiﬁcation
The protein concentration was estimated by the Bradford meth-
od using bovine serum albumin as the standard (Bradford, 1976).2.16. Statistical analysis
Individual dependent variable data were analyzed statistically
by one-way (TBARS, DPPH levels, phosphomolybdenum, Fe2+-che-
lating ability and cell viability) or two-way (thiol peroxidase, thiol
oxidase and TrxR activity) analysis of variance (ANOVA), followed
by Duncan’s multiple range test when appropriate. Differences be-
tween groups were considered to be signiﬁcant when p < 0.05.
Data are expressed as means ± SEM and each experimental proce-
dure was performed in at least 4 individual experiments with 3
replicates each. The compound concentration that causes 50% inhi-
bition (IC50) and the maximal inhibition of compounds (Imax) was
determined by linear regression analysis from 4 individual experi-
ments, using Graph Pad Prism software.3. Results
3.1. Effect of compounds on lipid peroxidation induced by Fe(II) and
SNP in rat brain
We induced lipid peroxidation in rat brain (Fig. 2) homogenates
with Fe(II) (10 lM) and SNP (5 lM), and the antioxidant effect of
selenium compounds on these homogenates was investigated. C1
had a protective effect against lipid peroxidation at the concentra-
tion range (25–50 lM), while the other compounds (C2, C3 and C4)
demonstrated a signiﬁcant effect from the lowest concentration
tested (Fig. 2A). In SNP-induced rat brain homogenates, the mono-
selenides presented a signiﬁcant antioxidant effect at the concen-
tration range (12.5–50 lM) for C1 and (25–50 lM) for C2, while
the diselenides showed a signiﬁcant effect at 6.25 lM (Fig. 2B).
The IC50 values of the compounds followed the order
C4 < C3 < C2 < C1 against Fe(II)-induced lipid peroxidation (Table
1). For SNP-induced lipid peroxidation, the IC50 values of the com-
pounds followed the order C4 < C3 < C2 < C1 (Table 1).
The Imax values of the compounds against Fe(II)-induced lipid
peroxidation was 87%, 92%, 93% and 96% respectively of C1 to C4
(Table 3). For SNP-induced lipid peroxidation, the Imax values of
the compounds was 83%, 90%, 91% and 92% respectively of C1 to
C4 (Table 3).
Fig. 2. Effect of the selenium compounds on TBARS production in the brain. The compounds were tested at ﬁnal concentrations of 6.25, 12.5, 25 and 50 lM, and the results
are expressed as a percentage (means ± SEM) relative to the Fe(II)-induced (A) or SNP-induced (B) control. Data is shown as means ± SEM of 4 individual experiments (3
replicates each).  Represents a signiﬁcant difference when compared with the induced group by Duncan’s multiple range test.
Table 1
Calculated IC50 values of compounds on lipid peroxidation in rat brain.
Compound IC50 (lM) for Fe(II) IC50 (lM) for SNP
C1 27.67 ± 1.28 20.12 ± 0.44
C2 13.78 ± 2.28 18.77 ± 0.14
C3 5.90 ± 1.32 9.01 ± 0.12
C4 4.73 ± 1.17 3.56 ± 0.15
Data are expressed as mean ± S.E.M and are calculated for fourth independent
assays.
Table 2
Calculated IC50 values of compounds on lipid peroxidation in rat liver.
Compound IC50 (lM) for Fe(II) IC50 (lM) for SNP
C1 33.71 ± 1.72 38.70 ± 0.93
C2 18.73 ± 1.25 17.26 ± 0.41
C3 28.93 ± 2.05 14.18 ± 0.23
C4 18.23 ± 1.12 3.38 ± 0.21
Data are expressed as mean ± S.E.M and are calculated for fourth independent
assays.
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SNP in rat liver
Rat liver homogenates were induced with Fe(II) or SNP to cause
lipid peroxidation, and the effect of selenium compounds on this
lipid peroxidation was investigated (Fig. 3). Both the monosele-
nides and the diselenides decreased the lipid peroxidation induced
by Fe(II) at the concentration range (25–50 lM) (Fig. 3A). However,
during SNP-induced lipid peroxidation (Fig. 3B), the C1 compoundFig. 3. Effect of the selenium compounds on TBARS production in the liver. The compoun
expressed as a percentage (means ± SEM relative to the Fe(II)-induced (A) or SNP-induced
each).  Represents a signiﬁcant difference when compared with the induced group by Dpresented a signiﬁcant effect only at the highest concentration
tested, while compounds C2 and C3 had signiﬁcant effects at the
concentration range (25–50 lM). The C4 compound was effective
in reducing the lipid peroxidation at the lowest concentration
tested.
The IC50 values of the compounds followed the order:
C4 < C2 < C3 < C1 against Fe(II)-induced lipid peroxidation (Table
2). For SNP-induced lipid peroxidation, the IC50 values of the com-
pounds followed the order: C4 < C3 < C2 < C1 (Table 2).ds were tested at ﬁnal concentrations of 6.25, 12.5, 25 and 50 lM, and the results are
(B) control. Data is shown as means ± SEM of 4 individual experiments (3 replicates
uncan’s multiple range test.
Table 4
Calculated Imax values of compounds on lipid peroxidation in rat liver.
Compound Imax (%) for Fe(II) Imax (%) for SNP
C1 67.18 ± 1.9 69.94 ± 3.4
C2 81.97 ± 1.7 79.63 ± 3.1
C3 72.29 ± 2.2 89.33 ± 2.8
C4 90.39 ± 2.1 93.21 ± 1.6
Data are expressed as mean ± S.E.M and are calculated for fourth independent
assays.
Fig. 4. Total antioxidant activity of the monoselenides and diselenides were
measured by the phosphomolybdenum assay. The compounds (400 lM) were
incubated with 0.6 M sulfuric acid, 28 mM sodium phosphate and 4 mM ammo-
nium molybdate for 90 min: (a–e) represent the effect of ascorbic acid. Values are
expressed as absorbance means ± SEM of 4 individual experiments (3 replicates
each).
Table 3
Calculated Imax values of compounds on lipid peroxidation in rat brain.
Compound Imax (%) for Fe(II) Imax (%) for SNP
C1 87.11 ± 5.1 83.03 ± 2.1
C2 92.66 ± 2.9 90.99 ± 1.1
C3 93.03 ± 3.2 91.01 ± 2.3
C4 96.37 ± 2.3 92.32 ± 2.6
Data are expressed as mean ± S.E.M and are calculated for fourth independent
assays.
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peroxidation was 67%, 81%, 72% and 90% respectively of C1 to C4
(Table 4). For SNP-induced lipid peroxidation, the Imax values of
the compounds was 69%, 79%, 89% and 93% respectively of C1 to
C4 (Table 4).3.3. Fe(II)-chelating property, free radical scavenging (DPPH), thiol-
oxidase activity and cell viability
The organoselenium compounds did not show any signiﬁcant
effects in tests involving Fe(II)-chelating properties, free radical
scavenging, thiol-oxidase activities and cellular viability (data not
shown).3.4. Total antioxidant activity
The curve of ascorbic acid was determine utilizing the concen-
tration 5, 10, 20, 40 and 80 lM represented at Fig. 4 as the letters
a–e. The diselenides at 400 lM showed total antioxidant activity
similar to ascorbic acid at 10, 20 and 40 lM. Similarly, the mono-
selenides at 400 lM demonstrated an antioxidant effect equivalent
to that of ascorbic acid at 5, 10 and 20 lM.3.5. Determination of thiol-peroxidase-like activity
Fig. 5 demonstrates the GPx activity of the organoselenium
compounds. The compounds C1 (Fig. 5A) and C2 (Fig. 5B) did not
present any signiﬁcant GPx activity when compared with the con-
trol group. DMSO alone had no signiﬁcant effect on the GPx activ-
ity. However, our data reveals that DPDS, C3 (Fig. 5C) and C4
analogs (Fig. 5D) at both concentrations tested demonstrated
GPx-like activity.3.6. NADPH oxidation by TrxR using C1–C4 as substrates
The monoselenides did not show TrxR activity, while the disel-
enides demonstrated a signiﬁcant difference compared to the con-
trol group. As shown in Fig. 6, C3 and C4 demonstrated 13 and 7
times higher TrxR activity, respectively, than the control.4. Discussion
The present study aimed to investigate and clarify the antioxi-
dant properties of novel mono- and diselenides compounds. Oxida-
tive stress is involved in various metabolic disorders and in the
normal process of aging (Giles et al., 2012; Mugesh et al., 2001).
Additionally, antioxidant therapy has been used in an attempt to
repair these harmful effects (Nogueira and Rocha, 2011; Zadra
et al., 2012). In this context, lipid peroxidation products MDA
and 4-hydroxynonenal have been shown to play signiﬁcant roles
in brain and liver toxicities and can serve as markers of oxidative
damage (Chen et al., 2005). Prestes reported that monoselenides,
which possess an amino group near the selenium, exhibited de-
creased MDA formation compared to that found for DPDS (Prestes
et al., 2012). The novel mono- and diselenides compounds exam-
ined in our study demonstrated antioxidant activity against Fe
(II)- and SNP-induced lipid peroxidation in rat brain and liver
homogenates. We also showed that the b-selenoamines had a sim-
ilar antioxidant effect as the diselenides in rat liver homogenates
following Fe(II)-induced oxidation. The antioxidant effect on lipid
peroxidation demonstrated by the diselenide compounds was
more pronounced than that of the monoselenide compounds.
These results support the assumption that the presence of the ami-
no group decreases selenol formation.
Additionally, using a total antioxidant activity assay, we dem-
onstrated that the diselenides presented a greater antioxidant
activity than the monoselenides when compared with equivalents
of ascorbic acid. The presence of an amino group in the structure of
organoselenium compounds was shown to reduce their antioxi-
dant activity (Sabir et al., 2012). Conversely, the inclusion of a
methyl and a methoxy group in the diselenides C3 and C4 does
not interfere in the antioxidant activity and most likely maintains
the formation of the two selenol structures.
Similarly, the effect of antioxidant compounds on DPPH radical
scavenging is involved with their capacity to donate a hydrogen
atom. Ogunmoyole et al. reported that DPDS had no signiﬁcant ef-
fect on ability to decolorize the DPPH, and Prestes et al. reported
that b-selenoamines had negligible antioxidant properties in the
DPPH assay (Ogunmoyole et al., 2009; Prestes et al., 2012). Thus,
in the present study, we also demonstrated that the novel mono-
and diselenides did not present any scavenger effects on DPPH rad-
icals, suggesting that the antioxidant mechanism of action of
mono- and diselenides may not be related to their ability to donate
an electron or hydrogen radical.
Similarly, reducing power is related to the mechanism by which
antioxidant agents transfer an electron or hydrogen atom to oxi-
dants or free radicals (Ogunmoyole et al., 2009). Thus, it is possible
to assert that the compounds tested in the Fe(II)-chelating assay
Fig. 5. Determination of thiol-peroxidase-like activity of the organoselenium compounds C1 (A), C2 (B), C3 (C) and C4 (D) at 200 and 400 lM.  Signiﬁcant difference when
compared with the control group by Duncan’s multiple range test. Standard error values were omitted for the sake of clarity, and they were <5% of the respective means for 5
individual experiments (3 replicates each).
Fig. 6. TrxR activity of the compounds. ⁄ Signiﬁcant difference when compared
with the control group by Duncan’s multiple range test. Standard error values were
omitted for the sake of clarity, and they were <5% of the respective means for 5
individual experiments (3 replicates each).
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electron or hydrogen atoms.
Studies in the literature report that organoselenium compounds
can cause several toxic effects. These effects are associated with
the catalytic oxidation of thiol groups from GSH or from different
proteins or enzymes (Meotti et al., 2003; Nogueira et al.,
2003a,b). Thus, thiol group oxidation might cause enzyme activity
inhibition and can contribute to cellular toxicity (Nogueira and
Rocha, 2010). Santos suggested that organochalcogens exhibit
hemolytic and genotoxic actions in blood cells, which are most
likely linked to their thiol oxidase activity and preferential interac-
tion with sulfhydryl groups critical to enzyme function (Santos
et al., 2009). However, when we tested the novel mono- and disel-
enides, we did not observe any toxic effects in the cellular viabilityof human leukocytes. Similarly, the compounds examined in this
study showed no signiﬁcant difference in the thiol oxidase activity
when compared with the basal group. In agreement with these
observations, we propose that the novel mono- and diselenides
compounds have a low toxic potential because they did not dem-
onstrate any genotoxic effects and did not interact with sulfhydryl
groups in the same way as the classic organochalcogens.
Furthermore, we showed that the novel diselenides demon-
strated mimetic GPx-like activity as well as increased TrxR activity
when analyzed in vitro. The GPx enzyme neutralizes the toxic or
signaling effects of hydrogen and lipid peroxides (Arthur, 2000),
which is consistent with the fact that the novel diselenides, by hav-
ing GPx-like activity, also had a signiﬁcant inhibitory effect on lipid
peroxidation in brain and liver homogenates.
Similarly, TrxR exhibits a broad substrate speciﬁcity and can
therefore reduce many low molecular weight compounds, includ-
ing hydrogen peroxide and lipid hydroperoxides (Li et al., 2008).
Thus, according to the results obtained for the diselenides, it is pos-
sible that increased TrxR activity can be associated with a lipid per-
oxidation inhibitory effect.
Therefore, we hypothesize that the effects presented in this
study for the C3 and C4 compounds, the GPx mimetic effect, and
the increased TrxR activity should most likely be attributed to
the formation of selenol groups, such as p-methyl-selenol and
o-methoxy-selenol.
However, the presence of the basic amino acid inclusion in the
monoselenides did not allow the formation of selenol groups,
which explains the lack of GPx and TrxR activity. Therefore, the
monoselenide effects obtained in the TBARS assay as well as the
total antioxidant capacity may simply be due to the nucleophilicity
of the amino group near the selenium (Hassan et al., 2012).
In conclusion, structural additions made in classical organosele-
nium compounds allow the elucidation of antioxidant mechanisms
involved in these compounds, enabling the discovery of new drugs.
We observed that the inclusion of the amino group in the monosel-
S.T. Stefanello et al. / Toxicology in Vitro 27 (2013) 1433–1439 1439enides resulted in an antioxidant effect, but this effect was not as
signiﬁcant as that observed for the diselenides, which most likely
have a higher antioxidant effect due to the formation of selenol
groups, as well as their mimetic GPx activity and their elevated
TrxR activity.Conﬂicts of interest
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